These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2976858)

  • 1. Reduction of Lp(a) by different methods of plasma exchange.
    Schenck I; Keller C; Hailer S; Wolfram G; Zöllner N
    Klin Wochenschr; 1988 Dec; 66(24):1197-201. PubMed ID: 2976858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL-apheresis: results of longterm treatment and vascular outcome.
    Keller C
    Atherosclerosis; 1991 Jan; 86(1):1-8. PubMed ID: 2064631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
    Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
    [No Abstract]   [Full Text] [Related]  

  • 4. Removal of low density lipoproteins (LDL) from plasma: the state of the art.
    Klinkmann H; Behm E; Ivanovich P
    Int J Artif Organs; 1989 Apr; 12(4):207-10. PubMed ID: 2656536
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of cascade filtration plasmapheresis in two patients affected by familial hypercholesterolemia.
    Barbagallo CM; Averna MR; DiMarco T; Spano L; Scafidi V; Marino G; Camemi AR; Notarbartolo A
    J Clin Apher; 1995; 10(2):96-100. PubMed ID: 7592525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis, and changes of subfractionated plasma lipoproteins after plasmapheresis in heterozygous familial hypercholesterolemia.
    Homma Y; Mikami Y; Tamachi H; Nakaya N; Nakamura H; Goto Y
    Metabolism; 1987 May; 36(5):419-25. PubMed ID: 3574132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis.
    Homma Y; Mikami Y; Tamachi H; Nakaya N; Nakamura H; Araki G; Goto Y
    Atherosclerosis; 1986 Apr; 60(1):23-7. PubMed ID: 2423096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
    Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
    Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative analysis of plasmapheresis and cascade plasma filtration in the management of patients with hereditary hypercholesterolemia].
    Konovalov GA; Vedernikov AIu; Olfer'ev AM; Kukharchuk VV
    Ter Arkh; 1987; 59(11):84-7. PubMed ID: 3441873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous familial hypercholesterolemia. Selective removal of low-density lipoproteins by secondary membrane filtration.
    Leitman SF; Smith JW; Gregg RE
    Transfusion; 1989 May; 29(4):341-6. PubMed ID: 2718235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis.
    Donato LJ; Saenger AK; Train LJ; Kotzer KE; Lagerstedt SA; Hornseth JM; Basu A; Winters JL; Baudhuin LM
    J Clin Apher; 2014 Oct; 29(5):256-65. PubMed ID: 24420163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.
    Taylan C; Schlune A; Meissner T; Ažukaitis K; Udink Ten Cate FE; Weber LT
    J Clin Lipidol; 2016; 10(6):1303-1310. PubMed ID: 27919346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of genetic determinants of low density lipoprotein levels on lipoprotein (a).
    Hegele RA; Sutherland S; Robertson M; Wu L; Emi M; Hopkins PN; Williams RR; Lalouel JM
    Clin Invest Med; 1991 Apr; 14(2):146-52. PubMed ID: 1829402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between apolipoprotein(a) phenotype, lipoprotein(a) concentration in plasma, and low density lipoprotein receptor function in a large kindred with familial hypercholesterolemia due to the pro664----leu mutation in the LDL receptor gene.
    Soutar AK; McCarthy SN; Seed M; Knight BL
    J Clin Invest; 1991 Aug; 88(2):483-92. PubMed ID: 1830890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of plasmapheresis, cascade-filtration and dextran-sulfate adsorption apheresis with calculation of the recovery rate of lipids and lipoproteins.
    Schwartzkopff W; Nold A; Gräfenhahn H; von Baeyer H; Schwerdtfeger R
    Beitr Infusionsther; 1988; 23():103-11. PubMed ID: 2484763
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system.
    Yamamoto A; Yokoyama S; Satani M; Kikkawa T; Kishino B
    Prog Clin Biol Res; 1988; 255():357-66. PubMed ID: 3340645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.